Mechanism Responsible for the Decreased Hepatic NADPH Generation Rate in Rats with Bilateral Ureter Ligation-Induced Renal Failure(Biopharmacy)

スポンサーリンク

概要

• 論文の詳細を見る

• We previously reported that a decrease in hepatic NADPH generation results in reduced hepatic first-pass clearance of propranolol in rats with bilateral ureteral ligation (BUL)-induced renal failure. The aim of the present study was to evaluate the mechanisms responsible for the reduced NADPH generation in the supernatant of liver homogenates (SUP) obtained from rats with BUL. The NADPH generation in the SUP in the presence of NADP^+ was decreased in BUL rats as compared with control rats. After the addition of glucose-6-phosphate or 6-phosphogluconic acid, the increase in NADPH in the SUP of BUL rats was similar to that in control rats. The NADPH generation in the SUP after the addition of the ultrafiltrate of BUL rat SUP was smaller than that after the addition of the ultrafiltrate of control rat SUP. These findings suggest that the enzymatic activities in the pentose phosphate pathway were not decreased significantly in BUL rats, and that the decrease in the generation of NADPH in BUL rats was mainly caused by the decreased concentration of endogenous substrate(s) and/or the increased concentration of endogenous inhibitor(s) for the pentose phosphate pathway.

• 公益社団法人日本薬学会の論文
• 2005-09-01

著者

• Taguchi Masato

  Graduate School Of Medicine And Pharmaceutical Sciences Univ. Of Toyama

• Hashimoto Yukiya

  Graduate School Of Medicine And Pharmaceutical Sciences Univ. Of Toyama

• URAI Misato

  Graduate School of Pharmaceutical Sciences, University of Toyama

• Urai Misato

  Graduate School Of Pharmaceutical Sciences Toyama Medical And Pharmaceutical University

• Higashi Takashi

  Graduate School Of Pharmaceutical Sciences Toyama Medical And Pharmaceutical University

• Hashimoto Y

  Institute Of Molecular & Cellular Biosciences The University Of Tokyo

• Higashi Takashi

  Graduate School Of Pharmaceutical Sciences Toyama Medical And Pharmaceutical Univ.

関連論文

• Membrane Transport Mechanisms of Quinidine and Procainamide in Renal LLC-PK1 and Intestinal LS180 Cells
• Coordination of Divalent Metal Cation to Amide Group to Form Adduct Ion in FAB Mass Spectrometry: Implication of Zn^ in Enzymatic Hydrolysis of Amide Bond
• Thermostability of Doubly Glycosylated Recombinant Lysozyme
• EFFECT OF CYP2C POLYMORPHISMS ON THE PHARMACOKINETICS OF PHENYTOIN IN JAPANESE PATIENTS WITH EPILEPSY
• Population Pharmacokinetics of Phenytoin in Japanese Patients with Epilepsy : Analysis with a Dose-Dependent Clearance Model
• 1P084 サリドマイド・アナログの抗インフルエンザウイルス活性(蛋白質-機能(反応機構,生物活性など),第48回日本生物物理学会年会)
• Evaluation of Phenytoin Dosage Regimens Based on Genotyping of CYP2C Subfamily in Routinely Treated Japanese Patients
• α-Glucosidase Inhibitors with a 4, 5, 6, 7-Tetrachlorophthalimide Skeleton Pendanted with a Cycloalkyl or Dicarba-closo-dodecaborane Group
• Inhibitory and Stimulative Effects of Amiodarone on Metabolism of Carvedilol in Human Liver Microsomes
• Involvement of the CYP1A Subfamily in Stereoselective Metabolism of Carvedilol in β-Naphthoflavone-Treated Caco-2 Cells(Biopharmacy)
• Novel Retinoidal Tropolone Derivatives. Bioisosteric Relationship of Tropolone Ring with Benzoic Acid Moiety in Retinoid Structure
• Nonlinear Mixed Effects Model Analysis of the Pharmacokinetics of Metoprolol in Routinely Treated Japanese Patients(Biopharmacy)
• Structural Development of Benzhydrol-Type 1'-Acetoxychavicol Acetate (ACA) Analogs as Human Leukemia Cell-Growth Inhibitors Based on Quantitative Structure-Activity Relationship (QSAR) Analysis
• Structure-Based Design and Synthesis of Fluorescent PPARα/δ Co-agonist and Its Application as a Probe for Fluorescent Polarization Assay of PPARδ Ligands
• Fusarielin A as an Anti-angiogenic and Anti-proliferative Agent : Basic Biological Characterization
• Structural Development of Liver X Receptor (LXR) Antagonists Derived from Thalidomide-Related Glucosidase Inhibitors
• Development of Tubulin-Polymerization Inhibitors Based on the Thalidomide Skeleton
• Hydrolyzed Metabolites of Thalidomide : Synthesis and TNF-α Production-Inhibitory Activity
• Mono- and Dihydroxylated Metabolites of Thalidomide : Synthesis and TNF-α Production-Inhibitory Activity
• Effects of Immunomodulatory Derivatives of Thalidomide (IMiDs) and Their Analogs on Cell-Differentiation, Cyclooxygenase Activity and Angiogenesis
• Enhancement of All-trans Retinoic Acid-Induced HL-60 Cell Differentiation by Thalidomide and Its Metabolites(Communication to the Editor)
• N-Phenylphthalimide-Type Cyclooxygenase (COX) Inhibitors Derived from Thalidomide : Substituent Effects on Subtype Selectivity
• Thalidomide as a Nitric Oxide Synthase Inhibitor and Its Structural Development
• Conversion of Ca^ Salt of an Organic Compound to Its Li^+ Salt to Simplify the Fast Atom Bombardment Mass Spectrum
• Coordination of Sodium Cation to an Oxygen Function and Olefinic Double Bond to Form Molecular Adduct Ion in Fast Atom Bombardment Mass Spectrometry
• Pharmacokinetic Characterization of Transcellular Transport and Drug Interaction of Digoxin in Caco-2 Cell Monolayers(Biopharmacy)
• OJ-003 Influences of CYP2D6 Genotype on Plasma Concentrations of Carvedilol : a Comparison with Metoprolol and Bisoprolol(Cardiovascular pharmacology, basic/clinical-2 (H) OJ1,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific Meeting of
• Nonlinear Mixed Effects Model Analysis of the Pharmacokinetics of Routinely Administered Bepridil in Japanese Patients with Arrhythmias(Biopharmacy)
• Analysis of CYP2D6 Genotype in Relation to Bepridil Pharmacokinetics in Patients with Persistent Atrial Fibrillation(Arrhythmia, Pharmacological Therapy 2 (A), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
• Pharmacokinetic Variability of Routinely Administered Bisoprolol in Middle-Aged and Elderly Japanese Patients(Biopharmacy)
• The Genotype of CYP2D6 Determines Cardiac Responsiveness to β-adrenergic Stimulation in patients Treated with Metoprolol, but not with Bisoprolol(Cardiovascular Pharmacology, Basic/Clinical 2 (H), The 69th Annual Scientific Meeting of the Japanese Circula
• Pharmacokinetics of R- and S-Carvedilol in Routinely Treated Japanese Patients with Heart Failure(Biopharmacy)
• Effect of CYP2D6^*10 on the Pharmacokinetics of R- and S-Carvedilol in Healthy Japanese Volunteers(Biopharmacy)
• Development of Novel Chiral Urea Catalysts for the Hetero-Michael Reaction
• Specific Nonpeptide Inhibitors of Puromycin-Sensitive Aminopeptidase with a 2,4(1H,3H)-Quinazolinedione Skeleton
• Cyclooxygenase Inhibitors Derived from Thalidomide
• Asymmetric Synthesis of a 3-Acyltetronic Acid Derivative, RK-682, and Formation of Its Calcium Salt during Silica Gel Column Chromatography
• Population Pharmacokinetics of Higher-Dose Mizoribine in Healthy Male Volunteers(Biopharmacy)
• Intestinal Expression and Metabolic Activity of the CYP3A Subfamily in Female Rats(Biopharmacy)
• Nonlinear Mixed Effects Model Analysis of the Pharmacokinetics of Aripiprazole in Healthy Japanese Males(Biopharmacy)
• Membrane Transport Mechanisms of Mizoribine in the Rat Intestine and Human Epithelial LS180 Cells(Biopharmacy)
• The Apical Uptake Transporter of Levofloxacin is Distinct from the Peptide Transporter in Human Intestinal Epithelial Caco-2 Cells
• Directional Transcellular Transport of Bisoprolol in P-glycoprotein-expressed LLC-GA5-COL150 Cells, but not in Renal Epithelial LLC-PK_1 Cells
• Stereoselective Oxidation and Glucuronidation of Carvedilol in Human Liver and Intestinal Microsomes(Biopharmacy)
• Additional Notes on Clinical Repeated-Dose Pharmacokinetic Trials Applying a Peak-and-Trough Sampling Design to Estimate Oral Clearance
• Population Pharmacokinetics and Proton Pump Inhibitory Effects of Intravenous Lansoprazole in Healthy Japanese Males(Analytical Biochemistry)
• Pharmacokinetic Analysis of Transcellular Transport of Levofloxacin across LLC-PK_1 and Caco-2 Cell Monolayers(Biopharmacy)
• Simulation for Clinical Repeated-Dose Pharmacokinetic Trials Applying a Peak-and-Trough Sampling Design to Estimate Oral Clearance(Biopharmacy)
• UGT2B7^*3はR-, S-カルベジロールの体内動態に影響を及ぼさない
• LS180細胞におけるVDRリガンドのCYP3A4発現誘導活性の評価
• Stereoselective Metabolism of Carvedilol by the β-Naphthoflavone-Inducible Enzyme in Human Intestinal Epithelial Caco-2 Cells(Biopharmacy)
• Pharmacokinetics and Hepatic Extraction of Metoprolol in Rats with Glycerol-Induced Acute Renal Failure(Biopharmacy)
• 尿管結紮腎不全モデルラットにおけるビソプロロールの体内動態と薬効の解析
• Endogenous Uremic Substances are not Involved in the Reduced Hepatic Extraction of Metoprolol in Bilateral Ureter-Ligated Rats
• Multiple Regression Analysis of Pharmacogenetic Variability of Carvedilol Disposition in 54 Healthy Japanese Volunteers(Biopharmacy)
• Pharmacokinetic Analysis of Transcellular Transport of Quinidine across Monolayers of Human Intestinal Epithelial Caco-2 Cells(Biopharmacy)
• OJ-326 The Genotype of CYP2D6 Determines the Cardiovascular Responsiveness to Isoproterenol in Patients Treated with Metoprolol(Cardiovascular Pharmacology, Basic/Clinical 2 (H) : OJ39)(Oral Presentation (Japanese))
• Intestinal Absorption and Hepatic Extraction of Propranolol and Metoprolol in Rats with Bilateral Ureteral Ligation(Biopharmacy)
• A Simulation Study to Evaluate Limited Sampling Strategies to Estimate Area under the Curve of Drug Concentration versus Time Following Repetitive Oral Dosing: Limited Sampling Model versus Naive Trapezoidal Method
• Mechanism Responsible for the Decreased Hepatic NADPH Generation Rate in Rats with Bilateral Ureter Ligation-Induced Renal Failure(Biopharmacy)
• Population pharmacokinetics of mizoribine in adult recipients of renal transplantation
• Population pharmacokinetics of mizoribine in pediatric recipients of renal transplantation

もっと見る 閉じる

スポンサーリンク